Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 22, 2024 | 2.62 | -2.24 |
Hansa Biopharma | HNSA | Nov 22, 2024 | 30.68 | +2.68 |
Hanza AB | HANZA | Nov 22, 2024 | 68.05 | +3.81 |
Harm Reduction Group | NOHARM | Nov 22, 2024 | 0.05 | +0.38 |
Havsfrun Investment | HAVS | Nov 22, 2024 | 13.70 | +4.58 |
Havsfrun Investment B | HAVB | Nov 22, 2024 | 13.70 | +4.58 |
Haypp Group | HAYPP | Nov 22, 2024 | 61.20 | +2.34 |
Headsent | VIMAB | Nov 22, 2024 | 7.50 | -3.23 |
Heba B | HEBAB | Nov 22, 2024 | 31.30 | +2.29 |
Hedera Group | HEGR | Nov 22, 2024 | 2.42 | -3.20 |
Heimstaden Pref | HEIMPREF | Nov 22, 2024 | 14.04 | -2.90 |
Heliospectra | HELIO | Nov 22, 2024 | 0.49 | -1.01 |
Hemnet Group | HEM | Nov 22, 2024 | 325.80 | +1.50 |
Hemply Balance | HMPLY | Nov 22, 2024 | 0.04 | +11.11 |
Hernö Gin B | HERNOB | Nov 22, 2024 | 3.85 | -1.41 |
Hexagon B | HEXAB | Nov 22, 2024 | 91.86 | +0.81 |
Hexagon Purus | HPURO | Nov 22, 2024 | 4.92 | 0.00 |
Hexatronic Group | HTRO | Nov 22, 2024 | 37.00 | +1.51 |
Hexicon | HEXI | Nov 22, 2024 | 0.17 | +4.40 |
Hexpol B | HPOLB | Nov 22, 2024 | 107.20 | +1.04 |
Hifab B | HIFAB | Nov 22, 2024 | 3.16 | +1.28 |
High Coast Distillery B | HIGHCOB | Nov 22, 2024 | 44.00 | +6.80 |
Hilbert | HILBB | Nov 22, 2024 | 5.54 | +2.21 |
HMS Networks | HMS | Nov 22, 2024 | 376.60 | +0.48 |
Hoegh Autoliners ASA | HAUTOO | Nov 22, 2024 | 132.50 | +0.99 |
Hoi Publishing AB | HOIB | Nov 22, 2024 | 0.17 | -6.59 |
Hoist Finance | HOFI | Nov 22, 2024 | 96.70 | +1.15 |
Holdflight | HOLDFL | Nov 22, 2024 | 0.16 | 0.00 |
Holmen A | HOLMA | Nov 22, 2024 | 408.00 | +0.99 |
Holmen B | HOLMB | Nov 22, 2024 | 411.00 | +0.74 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.